Dirk Lefeber has been appointed professor of Glycosylation Disorders, with effect from 1 July 2018. Lefeber leads the research group Glycosylation Disorders in Neurology.Glycosylation is a process by which proteins are modified with different sugars. Variations in this process occur with almost every disease. Although the biological language of our DNA and proteins is already well understood, this is certainly not the case for protein glycosylation.
To gain more insight into this, Dirk Lefeber investigates patients with hereditary metabolic disorders at Radboudumc. Amongst his most important findings is the discovery of several new molecular routes for the incorporation of sugars into the muscle. Understanding such abnormalities has already led to improved diagnostics and new therapies in patient care.
VidiDirk Lefeber (Elst, 1974) studied chemistry at Utrecht University and received his MSc, with honours, in 1997. In 2001, he obtained his PhD on synthetic carbohydrate vaccines against pneumococcal bacteria. He worked as a postdoctoral researcher in infectiology at the University Medical Center Utrecht and subsequently took a staff position in the department of Neurology and the Translational Metabolic Laboratory in Nijmegen. After undertaking a four-year training programme as a laboratory specialist clinical genetics, Lefeber built a research group in the field of Glycosylation Disorders.
He is also leader of the Radboudumc Expertise Center for Disorders of Glycosylation. Lefeber has received various national and international prizes, including a Vidi grant from the NWO.
ProteinsAs professor of Glycosylation Disorders in Neurology, he will focus on the mechanisms of protein glycosylation in (hereditary) neurological diseases. The Lefeber group is developing new technologies to study the glycosylation of proteins, and will use these widely to improve medical science. Through his research, he wants to gain new insights into the process of protein glycosylation in disease, and translate these into improved person-oriented care.
Related news items
Biomarkers found in COVID-19 patients support bradykinin hypothesis29 May 2020
A study into inflammatory substances in the blood of COVID-19 patients supports the hypothesis that kinins could play a role in the respiratory problems experienced by critically ill COVID-19 patients in IC. This discovery, published at MedRxiv, could lead to the development of new treatments.read more
Introducing OnePlanet Research Center webinar 5 June, 16:00 hrs.29 May 2020
OnePlanet Research Center develops digital technologies to create a society in which everyone can live a healthy life and has access to healthy and sustainable food. Radboudumc and Radboud University are amongst the founding partners. Find out what OnePlanet can do for you in this online session.read more
The impact of sex and gender in the COVID-19 pandemic29 May 2020
The case study of Sabine Oertelt-Prigione, developed by the European Commission’s H2020 Expert Group to update and expand "Gendered Innovations/Innovation through Gender", examines the impact of sex and gender in the current COVID-19 pandemic.read more
Terrestrial bacteria can grow on nutrients from space26 May 2020
Researchers from the Radboudumc describe in an article in Astrobiology that bacteria can survive on an 'extraterrestrial diet', which affected their pathogenic potential.read more